Back to search results

A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Renal Cell Carcinoma · Radiotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Clinique Claude Bernard, Albi, France

    Contact: Study coordinator (Laurent VOTRON, MD)
    Contact: Principal Investigator (Laurent VOTRON, MD)

  • Institut de Cancérologie de l'Ouest, Angers, France

    Contact: Study coordinator (Jérémy COLLIAUX, MD)
    Contact: Principal Investigator (Jérémy COLLIAUX, MD)

  • Institut Bergonié, Bordeaux, France

    Contact: Study coordinator (Paul SARGOS, MD)
    Contact: Principal Investigator (Paul SARGOS, MD)

  • Radiothérapie Bordeaux Nord Aquitaine, Bordeaux, France

    Contact: Study coordinator (Sigolène GALLAND-GIRODET, MD)
    Contact: Principal Investigator (Sigolène GALLAND-GIRODET, MD)

  • Centre François Baclesse, Caen, France

    Contact: Study coordinator (Nazim KHALLADI, MD) · n.khalladi@baclesse.unicancer.fr · +33 2 31 45 50 50
    Contact: Study coordinator (Jean-Michel jm.grellard@baclesse.unicancer.fr) · jm.grellard@baclesse.unicancer.fr · +33 2 31 45 50 02
    Contact: Principal Investigator (Nazim KHALLADI, MD)

  • Centre Jean Perrin, Clermont-Ferrand, France

    Contact: Study coordinator (Jessica MIROIR, MD)
    Contact: Principal Investigator (Jessica MIROIR, MD)

  • CHU Henri Mondor, Créteil, France

    Contact: Study coordinator (Yacid BELKACEMI, MD)
    Contact: Principal Investigator (Yacid BELKACEMI, MD)

  • Centre Georges François LECLERC, Dijon, France

    Contact: Study coordinator (Magali QUIVRIN, MD) · MQuivrin@cgfl.fr · 33 380 73 75 18
    Contact: Principal Investigator (Magali QUIVRIN, MD)

  • Institut de cancérologie de Bourgogne (Dijon, Auxerre, Chalon sur Saône), Dijon, France

    Contact: Study coordinator (Alexis LEPINOY, MD)
    Contact: Principal Investigator (Alexis LEPINOY, MD)

  • CHD Vendée, La Roche-sur-Yon, France

    Contact: Study coordinator (Emmanuelle REYGANE-VEYRA, MD) · emmanuelle.reygagne-viera@ght85.fr · 33 2 51 44 61 73
    Contact: Principal Investigator (Emmanuelle REYGANE-VEYRA, MD)

  • Centre de radiothérapie Guillaume le Conquérant, Le Havre, France

    Contact: Study coordinator (Romain MALLET, MD)
    Contact: Principal Investigator (Romain MALLET, MD)

  • Centre Oscar Lambret, Lille, France

    Contact: Study coordinator (David PASQUIER, MD) · d-pasquier@o-lambret.fr · 33 5 56 43 70 12
    Contact: Principal Investigator (David PASQUIER, MD)

  • Centre Léon Bérard, Lyon, France

    Contact: Study coordinator (Laurence BAWWENS, MD)
    Contact: Principal Investigator (Laurence BAWWENS, MD)

  • CHU La Timone, Marseille, France

    Contact: Study coordinator (Xavier MURACCIOLE, MD)
    Contact: Principal Investigator (Xavier MURACCIOLE, MD)

  • Institut Paoli Calmette, Marseille, France

    Contact: Study coordinator (Naji SALEM, MD)
    Contact: Principal Investigator (Naji SALEM, MD)

  • CHR, Metz, France

    Contact: Study coordinator (Xavier MICHEL, MD)
    Contact: Principal Investigator (Xavier MICHEL, MD)

  • ICM, Montpellier, France

    Contact: Study coordinator (David AZRIA, PhD)
    Contact: Principal Investigator (David AZRIA, PhD)

  • Institut de Cancérologie de Lorraine, Nancy, France

    Contact: Study coordinator (Anais STEFANI, MD)
    Contact: Principal Investigator (Anais STEFANI, MD)

  • Institut de Cancérologie de l'Ouest, Nantes, France

    Contact: Study coordinator (Stephane SUPIOT, MD)
    Contact: Principal Investigator (Stephane SUPIOT, MD)

  • Centre Antoine Lacassagne, Nice, France

    Contact: Study coordinator (Delphine BORCHIELLINI, MD) · Delphine.borchiellini@nice.unicancer.fr · 33 4 92 03 15 14
    Contact: Principal Investigator (Delphine BORCHIELLINI, MD)

  • Centre Haute Energie, Nice, France

    Contact: Study coordinator (Audrey CLAREN-MERCATI, MD) · audrey.claren@che-nice.com
    Contact: Principal Investigator (Audrey CLAREN-MERCATI, MD)

  • Institut Curie, Paris, France

    Contact: Study coordinator (CREHANGE Gilles, Pr)
    Contact: Principal Investigator (CREHANGE Gilles, Pr)

  • Groupement de radiothérapie Oncologie des Pyrénées, Pau, France

    Contact: Study coordinator (GILLIOT Olivier, MD) · ogilliot@gmail.com · 33 5 59 92 72 75
    Contact: Principal Investigator (GILLIOT Olivier, MD)

  • Centre Hospitalier Annecy Genevois, Pringy, France

    Contact: Study coordinator (CARBONNAUX Mélodie, MD) · mcarbonnaux@ch-annecygenevois.fr · 33 4 50 58 52 55
    Contact: Principal Investigator (CARBONNAUX Mélodie, MD)

  • Centre Henri Becquerel, Rouen, France

    Contact: Study coordinator (Maximilien ROGE, MD) · maximilien.roge@chb.unicancer.fr · 33 2 32 08 24 70
    Contact: Principal Investigator (Maximilien ROGE, MD)

  • Institut de Cancérologie de la Loire Lucien Neuwirth, Saint-Etienne, France

    Contact: Study coordinator (Nicolas MAGNE, MD)
    Contact: Principal Investigator (Nicolas MAGNE, MD)

  • Polyclinique de l'Ormeau, Tarbes, France

    Contact: Study coordinator (Guillaume PEYRAGA, MD) · dr.peyraga@grop65.fr
    Contact: Principal Investigator (Guillaume PEYRAGA, MD)

  • IUCT, Toulouse, France

    Contact: Study coordinator (Jonathan KHALIFA, MD)
    Contact: Principal Investigator (Jonathan KHALIFA, MD)

  • Centre marie Curie, Valence, France

    Contact: Study coordinator (Jean-Baptiste GUY, MD)
    Contact: Principal Investigator (Jean-Baptiste GUY, MD)

  • Institut Gustave Roussy, Villejuif, France

    Contact: Study coordinator (Mario TERLIZZI, MD)
    Contact: Principal Investigator (Mario TERLIZZI, MD)
View source on ClinicalTrials.gov(opens in a new tab)